• Insight Molecular Diagnostics appointed Donnie Purto as senior vice president of sales to lead commercialization ahead of the planned GraftAssureDx launch.
• Purto has more than 20 years of diagnostics, life sciences, and healthcare sales experience, including a decade at Natera in senior commercial roles.
• GraftAssureDx, an in vitro diagnostic kit for donor-derived cell-free DNA testing in transplant care, remains under FDA medical device review.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610140800PRIMZONEFULLFEED9845298) on October 14, 2026, and is solely responsible for the information contained therein.